Laman UtamaCYBN • NYSEAMERICAN
add
Cybin Inc
$7.05
Selepas Waktu Dagangan:(0.00%)0.00
$7.05
Tutup: 22 Apr, 4:00:03 PTG GMT-4 · USD · NYSEAMERICAN · Penafian
Tutup sebelumnya
$7.29
Julat hari
$6.90 - $7.45
Julat tahun
$4.81 - $14.44
Bilangan Purata
257.27K
Nisbah P/E
-
Hasil dividen
-
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CAD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 31.33J | 15.94% |
Pendapatan bersih | -10.54J | 65.24% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.53 | 84.50% |
EBITDA | -31.28J | -16.41% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CAD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 136.29J | 249.47% |
Jumlah aset | 253.55J | 95.45% |
Jumlah liabiliti | 13.31J | 56.49% |
Jumlah ekuiti | 240.24J | — |
Syer tertunggak | 21.04J | — |
Harga kepada buku | 0.61 | — |
Pulangan pada aset | -30.36% | — |
Pulangan pada modal | -31.62% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CAD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -10.54J | 65.24% |
Tunai daripada operasi | -27.12J | -4.15% |
Tunai daripada pelaburan | -303.00K | -104.06% |
Tunai daripada pembiayaan | -179.00K | -100.45% |
Perubahan bersih dalam tunai | -18.03J | -186.34% |
Aliran tunai bebas | -17.34J | -88.49% |
Perihal
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Diasaskan
2019
Ibu pejabat
Tapak web
Pekerja
50
